Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study

Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription – a multilevel methodological approach

“…at the level of the patient, prescriber, HCC, HCA, or health care district). However, few studies have aimed to understand the relative importance of these different levels [7,26,27,37,44]. Moreover, even if adherence with guidelines in general is a well-developed research topic [1-3], as far we know only to investigations have been focused on adherence to guidelines of statin prescription, [45,46] and only our current and previous work has applied multilevel regression analyses [9].…”

“…Therefore, adherence to prescription guidelines has attracted considerable interest in many countries [1-3], including Sweden [4-6]. However, it is still insufficiently known to what extent guidelines from the drug committees are followed and the factors that at different levels of the health care condition prescription adherence to recommended medication [4,7,8]. …”

Understanding non-adherence in chronic heart failure: a mixed-method case study

“…Only few studies report about limitations in terms of medical restrictions, co-morbidities or polypharmacy 16 18 23 24…”

Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database

“…Moreover guidelines may also be an aid for prescribers that are hardly able to assimilate the increasing volume of new scientific information [1,[3][4][5]. Even though the investigation of adherence to guidelines is attracting increasing interest, it is still not sufficiently understood what and how factors at different levels of the health care organization condition adherence to guidelines [6][7][8][9].…”